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http://dx.doi.org/10.1016/j.hjc.2015
1109-9666/ª 2016 Hellenic Cardiologi
license (http://creativecommons.org/Abstract A 19-year-old male was admitted to our clinic with a diagnosis of suspected acute
pericarditis and acute coronary syndrome. The initial diagnostics at our clinic revealed fulmi-
nant myocarditis. Twenty-four hours after admission, the patient’s condition deteriorated, and
he required mechanical ventilation and cardiopulmonary resuscitation. Unfortunately, the pa-
tient died. Clinical course, postmortem pathohistological findings and virus serology indicated
that an H1N1 viral caused fulminant myocarditis and was the primary manifestation.
ª 2016 Hellenic Cardiological Society. Publishing services by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Brief Introduction
Fulminant myocarditis is one of the major causes of acute-
onset heart failure and is responsible for approximately
10%-20% of cases sudden death among young patients anddovic, MD, PhD, Kopaonic^ka
vac, Serbia. Tel.: þ381 64
.com (G. Davidovic).
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.06.001
cal Society. Publishing services by
licenses/by-nc-nd/4.0/).6%-10% of cases of recent-onset dilative cardiomyopathy.1
Myocardial involvement in seasonal influenza infection has
been reported in up to 10% of cases,2 although the fre-
quency of myocarditis in H1N1 influenza remains unclear.
The presentation of influenza myocarditis varies from
asymptomatic infection to early fulminant myocarditis,
cardiogenic shock and eventually death, whereas compli-
cations ranges from arrhythmias, atrioventricular (AV)
blocks, congestive heart failure, cardiac tamponade,
disseminated intravascular coagulation, septic shock, renal
failure, alveolar hemorrhage, viral pneumonia and multi-
system organ failure3.Elsevier B.V. This is an open access article under the CC BY-NC-ND
Figure 1 ECG at admission: ST elevations in the anterolateral and inferior leads.
Figure 2 Chest X-ray of patient: bilateral, parahilar shadows
with pronounced lung interstitium.
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A 19-year-old male was admitted to our clinic from a hos-
pital in Cacak with a diagnosis of acute pericarditis and
suspected acute coronary syndrome. He was hospitalized
the previous day due to constant chest pain that had begun
during the night. Two days before admission, the patient
had been chopping wood after which he felt sweaty and
chill. Laboratory analyses from the Cacak hospital showed
elevated cardiac specific enzymes (CK-MB 112 U/L and
troponin I 1.1 mg/mL) but no elevations in markers of
inflammation (CRP 3 mg/L, WBC 8.6 109 /L).
The initial ECG in our clinic (Figure 1) showed ST
elevation in the anterolateral and inferior leads with single
PVCs, whereas echocardiography showed small circumfer-
ential pericardial effusion, measuring 2-3 mm, without any
abnormalities (ejection fraction 50%, left ventricular end-
systolic diameter 32 mm, left ventricular end-diastolic
diameter 49.3 mm, and thickness of ventricular septum
11 mm). Laboratory investigations revealed elevated in-
flammatory markers (CRP 13 mg/L, WBC 13.3 x109/L and
fibrinogen 3.519 g/L) and elevated cardiac specific enzymes
(CK-MB 335 U/L and troponin I 35.34 mg/mL), followed by
coronary angiography indicating normal findings in the
coronary arteries, except a small muscle bridge in the LAD
with TIMI III flow. Because the ECG elevation persisted, the
patient was transferred to the Coronary Unit with non-
steroid antirheumatic and gastroprotective therapy in
addition to anticoagulant, antiarrhythmic and antibiotic
therapy.
Several hours after admission, patient’s condition wors-
ened with increased chest pain and cough with expectora-
tion of bloodstained sputum. His blood pressure lowered to
90/60 mmHg with increased heart rate, and the ECG showed
incomplete right bundle branch blockage with previously
described ST elevations. Laboratory results indicated
further elevation of cardiac specific enzymes (CK-MB
1049 U/L and troponin I 74 mg/mL) along with increased
transaminases and positive inflammation markers (AST 1239
CRP 13 mg/L). Chest X-ray showed bilateral stain, parahilar
shadows and pronounced lung interstitium. Low oxygen
saturation was corrected with oxygen and administration of
diuretics, after which blood gas analysis showed normal
oxygen saturation and pO2.
Later during the day, the patient’s condition deterio-
rated further. He was subfebrile with 62% oxygen saturation
and arterial blood pO2 of 4.8 KPa. He remained resistant to
treatment with diuretics and oxygen and had to be intu-
bated and connected to mechanical ventilation. Repeated
chest X-ray showed progression, of non-cardiogenic pul-
monary edema compared with previous X-rays and mildsigns of acute respiratory distress syndrome (Figure 2).
Blood pressure was maintained at 100/60 mmHg with
inotropic support. The patient was unstable in the next few
hours with mixed acidosis and low pO2. We immediately
started intensive resuscitation measures and the use of
antibiotics, bronchodilators, cardiotonic, anticoagulants,
antacids, antiarrhythmic drugs, inotropes, analgesics and
vitamins. Despite intensive therapy and reanimation mea-
sures, significant hemodynamic instability with bradycardia
and asystole occurred.
Histopathological findings from representative regions of
the left ventricle (anterior, lateral and posterior walls),
apex, septum and right ventricle (Figure 3) indicated
extensive zones of necrosis along with degenerative myo-
cardiocytes and inflammatory infiltrate. The inflammatory
infiltrate was dominated by neutrophilic leukocytes inter-
spersed with areas of degenerated cardiomyocytes
(Figure 3A). The inflammatory infiltrate was much scarcer
and generally consisted of lymphocytes alone or clustered
in groups of two to six cells distributed along the sarco-
lemma and often achieving close contact with this region
(Figure 3B). The left ventricle showed a necrotic zone with
leukocytes and a degenerative zone with lymphocytic
infiltrate (Figure 3C). Additionally, the right ventricle was
infiltrated with massive lymphocyte and leukocyte inflam-
mation (Figure 3D). The lungs showed abundant edemic
liquid that filled the interstitium and intraalveolar spaces,
with lymphocytes, erythrocytes, alveolar epithelial cells
and rare neutrophils, macrophages and hemosiderophages.
The blood vessels were dilated and filled with blood and
Figure 3 Histopathological findings (H&E stained, original magnification, 100 (Figure 3c, 3d, 3f), 200 (Figure 3a, 3e) and 400
(Figure 3b): Figure 3a e Left ventricle e Inflammatory infiltrate dominated by neutrophilic leukocytes. Figure 3b e Lymphocytes in
contact with sarcolemma, degenerative altered cardiomyocytes with granular, brown pigments indicating lipofuscin. Figure 3c e Left
ventricle showed necrotic zone with leukocytes and degenerative zone with lymphocytic infiltrate. Figure 3d e Right ventricle
infiltrated with massive lymphocyte and leukocyte inflammation. Figure 3e e Lungs e lung edema and focus of inflammation
(lymphocytes, erythrocytes, alveolar epithelial cells and rare neutrophils, macrophages and hemosiderophages) with thrombosis of a
blood vessel. Figure 3f e Lung edema, bronchial lumen filled with inflammatory exudate and inflammatory infiltrate forming small
bronchopneumonia foci.
Fulminant myocarditis as a primary manifestation of H1N1 infection 183agglutinated erythrocytes (Figure 3E). The bronchial lumen
was filled with inflammatory exudate and inflammatory
infiltrate that permeated the wall and form small bron-
chopneumonia foci (Figure 3F).
Postmortem hemoculture was negative, whereas ELISA
virus serology showed elevated IgM antibodies only for H1N1
virus and negative for other viruses.3. Discussion
In most cases, fulminant myocarditis is caused by coxsackie
B virus, whereas the incidence of H1N1-associated
myocarditis is the subject of debate. Ukimura et al. re-
ported 29 patients with H1N1 myocarditis within a 2-yearobservation period in Japan, and 17 of these patients had
fulminant myocarditis with fatal arrhythmias or varying
degrees of cardiogenic shock4 among 20.62 million patients
infected with influenza A H1N1 in 2009.5 However, the
prevalence of H1N1 influenza, as well as fulminant
myocarditis as a complication of H1N1 infection, in Serbia is
unknown. At the time of this report, no cases of fulminant
myocarditis as a complication of H1N1 infection have been
reported in Serbia.
The pathogenesis of H1N1 myocarditis differs from other
forms of myocarditis. Significant mechanisms of cardiac
injury, such as cytokine storm, with a massive release of
proinflammatory cytokines into the circulation, oxidative
stress and endothelial dysfunction, could play amajor role in
disease pathogenesis.3 The clinical presentation of H1N1
184 G. Davidovic et al.myocarditis varies greatly; cardiac dysfunction has pro-
gressed rapidly in 12 out of 15 patients (aswealso observed in
our patient), whereas 10 patients had fatal arrhythmias and/
or cardiogenic shock. Cardiopulmonary arrest was the first
cardiac symptom described in only two out of 15 patients.3
The development of viral myocarditis requires direct
myocardial injury with the release of intracellular antigens,
followed by an immune response directed against the
pathogens.6 On cardiac biopsy, lymphocyte infiltration and
myocyte damage are typically present. Ultimately, the
body can clear the virus, leading to recovery, or the
infection can become chronic, leading to cardiomyopathy.6
The myocardium of our patient was completely involved
with a severe form of inflammation and inflammatory
infiltrate dominated by lymphocytes that were in close
contact with the sarcolemma, indicated that he had
already developed lymphocytic, viral, myocarditis.
H1N1 infection is a respiratory infection with primary
changes affecting the lung tissue. Progressive pneumonia,
acute respiratory distress syndrome, multiorgan failure are
major but not so rare forms of this infection. Inflammation
in the lungs leads to the development of acute respiratory
distress syndrome and impaired gas exchange with systemic
release of inflammatory mediators, causing inflammation,
hypoxemia and metabolic acidosis. Acute respiratory
distress syndrome is associated with the highest mortality
rate and clinical presentation of dyspnea, cyanosis,
tachypnea, diaphoresis, use of accessory muscles of respi-
ration, cough, and chest pain. Our post-mortem, patho-
histological findings from the lungs of our patient document
pulmonary edema and pneumonitis rather than a picture of
diffuse alveolar damage, which is the usual morphologic
correlate of acute respiratory distress syndrome.7
The course of disease in our patient demonstrated that
fulminant myocarditis was the primary manifestation of
H1N1 infection. Our assumption is based on the initial
symptoms and signs ofmyocarditis that developed, including
chest pain, ECG changes and elevated cardiac specific en-
zymes but no evidence of elevated inflammatory markers.
After two days of his illness, he developed signs of pulmo-
nary infection and pneumonitis and was admitted to the
hospital. Using an advanced literature search, we could notfind any similar case reports, as well as no proven patho-
physiological mechanisms that could explain the primary
manifestation of H1N1 infection as fulminant myocarditis.
4. Conclusions
By analyzing and summarizing the entire clinical course and
histopathological findings, we conclude that this fulminant
myocarditis was the primary manifestation of H1N1 virus
infection and that this report is the first described case
report of such H1N1 infection. Additionally, to the best of
our knowledge, this report describes the only case of H1N1
fulminant myocarditis from Serbia.References
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